Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention.

Genuis SJ, Bouchard TP.

J Environ Public Health. 2012;2012:354151. doi: 10.1155/2012/354151. Epub 2012 Jan 15.

2.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
3.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005326. Review.

PMID:
17054253
4.

The use of combination therapy in the treatment of postmenopausal osteoporosis.

Compston J.

Endocrine. 2012 Feb;41(1):11-8. doi: 10.1007/s12020-011-9554-2. Epub 2011 Oct 29. Review.

PMID:
22038453
5.
6.

Osteoporosis treatment in postmenopausal women with pre-existing fracture.

Cheng MH, Chen JF, Fuh JL, Lee WL, Wang PH.

Taiwan J Obstet Gynecol. 2012 Jun;51(2):153-66. doi: 10.1016/j.tjog.2012.04.001. Review.

7.

How to manage postmenopausal osteoporosis?

Body JJ.

Acta Clin Belg. 2011 Nov-Dec;66(6):443-7. Review.

PMID:
22338309
8.

Treatment for osteoporosis in people with ß-thalassaemia.

Bhardwaj A, Swe KM, Sinha NK, Osunkwo I.

Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2. Review.

PMID:
26964506
9.

[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].

Shiraki M.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53. Review. Japanese. No abstract available.

PMID:
18161147
10.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
11.
12.

Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.

Brandi ML.

Curr Med Res Opin. 2010 Nov;26(11):2553-63. doi: 10.1185/03007995.2010.519658. Epub 2010 Sep 21. Review.

PMID:
20858031
13.

Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.

Boonen S.

Curr Opin Rheumatol. 2006 Jun;18 Suppl 1:S21-7. Review.

PMID:
16735842
14.

[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].

Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA.

Z Rheumatol. 2003 Dec;62(6):512-7. Review. German.

PMID:
14685711
15.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

16.

Strontium ranelate in the prevention of osteoporotic fractures.

Reginster JY, Malaise O, Neuprez A, Bruyere O.

Int J Clin Pract. 2007 Feb;61(2):324-8. Review.

PMID:
17263720
17.
18.

Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.

Gallacher SJ, Dixon T.

Calcif Tissue Int. 2010 Dec;87(6):469-84. doi: 10.1007/s00223-010-9420-x. Epub 2010 Sep 26. Review.

PMID:
20872215
19.

Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.

Cortet B.

Rheumatology (Oxford). 2009 Oct;48 Suppl 4:iv14-9. doi: 10.1093/rheumatology/kep275. Review.

PMID:
19783589
20.

Bisphosphonates for steroid-induced osteoporosis.

Allen CS, Yeung JH, Vandermeer B, Homik J.

Cochrane Database Syst Rev. 2016 Oct 5;10:CD001347. Review.

PMID:
27706804

Supplemental Content

Support Center